FLGT Operating Cash Flow
-$83.70MTTM · USD
Period ending:
FLGT FY Operating Cash FlowUSD
$538.58M-$101.64M
2014-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
FLGT operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -101,638,000 | |
| 21,060,000 | |
| 27,003,000 | |
| 253,520,000 | |
| 538,577,000 | |
| 140,628,000 | |
| 5,517,000 | |
| -675,000 | |
| 1,331,000 | |
| 4,405,000 | |
| -969,000 | |
| -4,397,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All FLGT financial metrics · FLGT stock overview · How to interpret financial metrics
